Colectomy in microscopic colitis: a rare indication

IF 23 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Gut Pub Date : 2024-08-30 DOI:10.1136/gutjnl-2024-333505
David Bergman, Anders Forss, Jiangwei Sun, Fahim Ebrahimi, Jonas F Ludvigsson
{"title":"Colectomy in microscopic colitis: a rare indication","authors":"David Bergman, Anders Forss, Jiangwei Sun, Fahim Ebrahimi, Jonas F Ludvigsson","doi":"10.1136/gutjnl-2024-333505","DOIUrl":null,"url":null,"abstract":"We read with great interest the systematic review by Honap et al 1 and commend the authors for highlighting the elevated risk of colectomy in patients with acute severe UC. While there is ample knowledge about colectomy as a last resort treatment in UC,2 little is known about the colectomy risk in microscopic colitis (MC).3–6 As the incidence of MC has been on the rise over the past decades,7 with current incidence rates (IRs) rivalling those of UC and Crohn’s disease,8 knowledge on the risk of colectomy in patients with MC is warranted. Leveraging the nationwide Swedish ESPRESSO histopathology cohort,9 we estimated the risk of colectomy in patients with biopsy-verified MC (diagnosed 1990–2017) compared with matched reference individuals from the general population (matched by age, sex, county of residence and calendar year). Colectomy was defined as having a corresponding surgical procedure code indicating total colectomy recorded in the National Patient Register (online supplemental table S1).### Supplementary data [gutjnl-2024-333505supp001.pdf] Follow-up began on the date of MC diagnosis (any of the subtypes of collagenous colitis or lymphocytic colitis) and on the matching date for the reference individuals. Study participants were followed until 31 December 2021 for colectomy, death, emigration or a medical …","PeriodicalId":12825,"journal":{"name":"Gut","volume":null,"pages":null},"PeriodicalIF":23.0000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gut","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/gutjnl-2024-333505","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We read with great interest the systematic review by Honap et al 1 and commend the authors for highlighting the elevated risk of colectomy in patients with acute severe UC. While there is ample knowledge about colectomy as a last resort treatment in UC,2 little is known about the colectomy risk in microscopic colitis (MC).3–6 As the incidence of MC has been on the rise over the past decades,7 with current incidence rates (IRs) rivalling those of UC and Crohn’s disease,8 knowledge on the risk of colectomy in patients with MC is warranted. Leveraging the nationwide Swedish ESPRESSO histopathology cohort,9 we estimated the risk of colectomy in patients with biopsy-verified MC (diagnosed 1990–2017) compared with matched reference individuals from the general population (matched by age, sex, county of residence and calendar year). Colectomy was defined as having a corresponding surgical procedure code indicating total colectomy recorded in the National Patient Register (online supplemental table S1).### Supplementary data [gutjnl-2024-333505supp001.pdf] Follow-up began on the date of MC diagnosis (any of the subtypes of collagenous colitis or lymphocytic colitis) and on the matching date for the reference individuals. Study participants were followed until 31 December 2021 for colectomy, death, emigration or a medical …
微小结肠炎的结肠切除术:罕见的适应症
我们饶有兴趣地阅读了 Honap 等人的系统综述1 ,并对作者强调急性重症 UC 患者切除结肠的风险较高表示赞赏。过去几十年来,MC 的发病率一直在上升7 ,目前的发病率(IRs)可与 UC 和克罗恩病媲美8 ,因此我们有必要了解 MC 患者切除结肠的风险。利用瑞典全国范围的ESPRESSO组织病理学队列9,我们估算了经活检证实的MC患者(1990-2017年确诊)与普通人群中的匹配参照个体(按年龄、性别、居住县和日历年匹配)的结肠切除风险。结肠切除术的定义是,在全国患者登记册(在线补充表 S1)中记录有相应的外科手术代码,表明进行了全结肠切除术(在线补充表 S1)。###补充数据 [gutjnl-2024-333505supp001.pdf]随访从 MC 诊断(胶原性结肠炎或淋巴细胞性结肠炎的任何一种亚型)之日起开始,并从参照个体的匹配日期开始。研究参与者将随访至 2021 年 12 月 31 日,包括结肠切除术、死亡、移民或医疗 ...
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Gut
Gut 医学-胃肠肝病学
CiteScore
45.70
自引率
2.40%
发文量
284
审稿时长
1.5 months
期刊介绍: Gut is a renowned international journal specializing in gastroenterology and hepatology, known for its high-quality clinical research covering the alimentary tract, liver, biliary tree, and pancreas. It offers authoritative and current coverage across all aspects of gastroenterology and hepatology, featuring articles on emerging disease mechanisms and innovative diagnostic and therapeutic approaches authored by leading experts. As the flagship journal of BMJ's gastroenterology portfolio, Gut is accompanied by two companion journals: Frontline Gastroenterology, focusing on education and practice-oriented papers, and BMJ Open Gastroenterology for open access original research.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信